Biopharma Co. Aridis Launches $28M IPO For Clinical Trials
By Rachel Graf ( August 6, 2018, 8:17 PM EDT) -- Biopharmaceutical company Aridis Pharmaceuticals Inc. launched an estimated $28 million initial public offering on Monday to help fund clinical trials involving immunotherapies for infectious diseases that are resistant to traditional drugs....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.